http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2296927-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c82fea9cd3dc48540ebd26d3b952479 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate | 2002-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff3fa819a3ffc845fa372b55a3aa86c0 |
publicationDate | 2008-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2296927-T3 |
titleOfInvention | BCMP-101, A PROTEIN ASSOCIATED WITH CANCER. |
abstract | An isolated polypeptide that: a) comprises or consists of the amino acid sequence shown in Figure 1 (SEQ ID NO: 1); b) is a derivative that has one or more amino acid substitutions, deletions or insertions with respect to the amino acid sequence shown in Figure 1 (SEQ ID NO: 1) that has a 95% sequence identity with the SEQ polypeptide ID NO: 1 and showing the immunological activity of said polypeptide. |
priorityDate | 2001-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 595.